Get startedLog in
    Picture of Corcept Therapeutics Incorporated logo

    CORT — Corcept Therapeutics Incorporated News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)

    Picture of Corcept Therapeutics Incorporated logoCorcept Therapeutics Incorporated
    15/04/2024 13:26
    April 15 (Reuters) - Corcept Therapeutics Inc  CORT.O :
    * CORCEPT COMPLETES ENROLLMENT IN PHASE 2 DAZALS TRIAL IN
PATIENTS
WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Source text for Eikon:  ID:nGNX7NCcSD 
Further company coverage:  CORT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Corcept Therapeutics Incorporated

    See all news